Medinova Diagno. Reports Consistent Revenue and Profit Growth, Low Debt Ratio

Revenue - Annually: Steady at Rs 12.5 Cr in the last 3 years. The company has maintained a consistent revenue stream.Profit Before Tax - Annually: Increased by 25% from the previous year, reaching Rs 1.5 Cr. This shows a positive growth trend for the company.
Net Profit - Annually: Improved by 20% from the previous year, reaching Rs 1.2 Cr. This indicates a healthy profit margin for the company.
Debt to Equity Ratio: Low at 0.2, indicating a strong financial position and low risk for investors.
Overall, Medinova Diagno. has shown steady financial performance in the last quarter, with positive growth in key areas such as operating cash flow, revenue, and profit. This is reflected in the recent stock call by MarketsMOJO, which has rated the stock as 'Sell'. However, it is important to note that this is not a recommendation, but rather a neutral assessment based on the company's financial results. As a microcap company in the hospital and healthcare services industry, Medinova Diagno. has shown potential for growth and stability in the market. Investors should carefully consider all available information before making any investment decisions.